1. Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers
   Qiang Feng et al, 2022, Frontiers in Immunology CrossRef
2. Chimeric Antigen Receptor-T Cell Therapy
   Ja Min Byun et al, 2022, The Korean Journal of Medicine CrossRef
3. Anticancer peptides as novel immunomodulatory therapeutic candidates for cancer treatment
   Apurva Sood et al, 2024, Exploration of Targeted Anti-tumor Therapy CrossRef
4. Innovations in Drug Delivery Strategies for Breast Cancer
   Mani Sharma et al, 2024, Latest Research on Breast Cancer [Working Title] CrossRef
5. Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome Interactions
   Rajamanikkam Kamaraj et al, 2024, Bioconjugate Chemistry CrossRef
6. In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy
   Tianqing Xin et al, 2022, Frontiers in Oncology CrossRef
7. Chimeric antigen receptor-T cell therapy-related cardiotoxicity in adults and children cancer patients: A clinical appraisal
   Massimiliano Camilli et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
8. Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy
   Mohammad Fereydouni et al, 2022, Frontiers in Oncology CrossRef
9. Not the comfy chair! Cancer drugs that act against multiple active sites
   Laurence Booth et al, 2019, Expert Opinion on Therapeutic Targets CrossRef
10. The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review
    Bibhu Prasad Satapathy et al, 2024, Frontiers in Immunology CrossRef
11. Tumor‐associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire
    Shaivy Malik et al, 2024, Cell Biology International CrossRef
12. Immunological tolerance in breast cancer: some reasons for development
    E. V. Kayukova et al, 2024, Advances in Molecular Oncology CrossRef
13. Epigenetics of Ageing and Psychiatric Disorders
    Cezar-Ivan Colită et al, 2024, Journal of Integrative Neuroscience CrossRef
14. Combined antitumor effects of anti-EGFR variant III CAR-T cell therapy and PD-1 checkpoint blockade on glioblastoma in mouse model
    Yujie Song et al, 2020, Cellular Immunology CrossRef
15. Autoimmune Pemphigus: Latest Advances and Emerging Therapies
    Yen Loo Lim et al, 2022, Frontiers in Molecular Biosciences CrossRef
16. Problems of clinical trials of cell therapy effectiveness today
    A. G. Popandopulo et al, 2021, Сибирский научный медицинский журнал CrossRef
17. Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer
    Mohammad Fereydouni et al, 2022, Frontiers in Oncology CrossRef
18. CAR-NK Cell Therapy: A Promising Alternative to CAR-T Cell Therapy
    Jinqiao Hu, 2022, Proceedings of the 2022 6th International Seminar on Education, Management and Social Sciences (ISEMSS 2022) CrossRef
19. Nano-sized warriors: zinc chromium vanadate nanoparticles as a dual solution for eradicating waterborne enterobacteriaceae and fighting cancer
    Suriya Rehman et al, 2023, Frontiers in Pharmacology CrossRef
20. Light-activated nanomaterials for tumor immunotherapy
    Fang Wang et al, 2022, Frontiers in Chemistry CrossRef
21. Engineering in Medicine To Address the Challenge of Cancer Drug Resistance: From Micro- and Nanotechnologies to Computational and Mathematical Modeling
    Morgan Craig et al, 2021, Chemical Reviews CrossRef
22. How to Test Human CAR T Cells in Solid Tumors, the Next Frontier of CAR T Cell Therapy
    Russell W. Cochrane et al, 2024, Cancer Immunotherapy CrossRef
23. Natural killer cells: Innate immune system as a part of adaptive immunotherapy in hematological malignancies
    Ivo Demel et al, 2022, American Journal of Hematology CrossRef
24. CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
    Sasan Ghaffari et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
25. A feasibility study comparing car-t cell therapy and separate limb end perfusion therapy in the treatment of melanoma
    Yuan Wen, 2023, Highlights in Science, Engineering and Technology CrossRef
26. Medicine of the future: personalized, stratified or precision? (literature review)
    Igor S. Dоlgopolov et al, 2023, HEALTH CARE OF THE RUSSIAN FEDERATION CrossRef
27. CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
    Anna Christina Dragon et al, 2023, Frontiers in Immunology CrossRef
28. Patients’ experience with chimeric antigen receptor T-cell therapy for DLBCL in China: a qualitative study
    Yiwen Mao et al, 2023, Supportive Care in Cancer CrossRef
29. Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy
    Veronique Beiss et al, 2022, Molecular Pharmaceutics CrossRef
30. Updating CAR-T Cell Immunotherapy for Liquid and Solid Tumor
    Ankita Singh et al, 2023, Diseases and Research CrossRef
31. Development of Cell and Gene Therapies for Clinical Use in the US and EU: Summary of Regulatory Guidelines
    Anand Rotte, 2025, Current Gene Therapy CrossRef
32. Chimeric Antigen Receptor T Cell Therapy and Its Significance in Multiple Myeloma
    Jaskamal Padda et al, 2021, Cureus CrossRef
33. IL-7 and CCR2b Co-Expression-Mediated Enhanced CAR-T Survival and Infiltration in Solid Tumors
    Guangchao Li et al, 2021, Frontiers in Oncology CrossRef
34. The ER-Mitochondria Interface as a Dynamic Hub for T Cell Efficacy in Solid Tumors
    Elizabeth G. Hunt et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
35. A tumor microenvironment gene set–Based prognostic signature for non-small-cell lung cancer
    Yingsheng Wen et al, 2022, Frontiers in Molecular Biosciences CrossRef
36. The role of immune cells in resistance to oncolytic viral therapy
    Prathibha Ambegoda et al, 2024, Mathematical Biosciences and Engineering CrossRef
37. Retinoblastoma cell-derived Twist protein promotes regulatory T cell development
    Ruishi Zhang et al, 2021, Cancer Immunology, Immunotherapy CrossRef
38. Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy
    Emanuela Stampone et al, 2023, Cellular and Molecular Life Sciences CrossRef
39. Employing CRISPR-Cas9 to Enhance T Cell Effector Function
    Julian J. Freen-van Heeren, 2024, Immune Homeostasis CrossRef
40. Recent advances and current challenges in CAR-T cell therapy
    R. Joy et al, 2024, Biotechnology Letters CrossRef
41. Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptome
    Kristina Pavlovic et al, 2024, Frontiers in Immunology CrossRef
42. Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
    Maria L. Guevara et al, 2020, Frontiers in Chemistry CrossRef
43. Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies
    Yangjie Liu et al, 2024, Recent Patents on Anti-Cancer Drug Discovery CrossRef
44. Strategies for HIV-1 suppression through key genes and cell therapy
    Alyona Sorokina et al, 2023, Frontiers in Medicine CrossRef
45. Mantle cell lymphoma: A clinical review of the changing treatment paradigms with the advent of novel therapies, and an insight into Indian data
    Vivek Sulekha Radhakrishnan et al, 2022, Cancer Reports CrossRef
46. Expectativas nuevas en la oncología: Inmunoterapia de células T con receptor de antígeno quimérico en neoplasias hematológicas
    Jayleen Stefanny Jiménez Jara et al, 2023, AlfaPublicaciones CrossRef